Ascentis Wealth Management LLC raised its stake in shares of Globe Life Inc. (NYSE:GL - Free Report) by 23,840.4% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 381,131 shares of the company's stock after buying an additional 379,539 shares during the period. Ascentis Wealth Management LLC owned approximately 0.49% of Globe Life worth $68,100,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Vanguard Group Inc. boosted its stake in Globe Life by 0.9% during the 4th quarter. Vanguard Group Inc. now owns 10,090,885 shares of the company's stock valued at $1,411,311,000 after purchasing an additional 86,349 shares in the last quarter. Invesco Ltd. lifted its holdings in shares of Globe Life by 2.7% in the fourth quarter. Invesco Ltd. now owns 3,948,676 shares of the company's stock valued at $552,262,000 after buying an additional 102,445 shares during the period. Dimensional Fund Advisors LP boosted its stake in Globe Life by 10.2% during the first quarter. Dimensional Fund Advisors LP now owns 2,353,192 shares of the company's stock valued at $327,479,000 after buying an additional 217,331 shares in the last quarter. Morgan Stanley boosted its stake in Globe Life by 7.2% during the fourth quarter. Morgan Stanley now owns 1,860,257 shares of the company's stock valued at $260,176,000 after buying an additional 125,567 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership boosted its stake in Globe Life by 32.9% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 1,435,247 shares of the company's stock valued at $200,734,000 after buying an additional 355,399 shares in the last quarter. 81.61% of the stock is currently owned by institutional investors.
Globe Life Stock Up 1.8%
GL stock opened at $181.07 on Friday. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.07 and a quick ratio of 0.07. The firm has a market capitalization of $13.92 billion, a P/E ratio of 12.02 and a beta of 0.48. Globe Life Inc. has a 52-week low of $127.85 and a 52-week high of $191.55. The company's 50 day simple moving average is $176.73 and its 200-day simple moving average is $157.11.
Globe Life (NYSE:GL - Get Free Report) last posted its quarterly earnings data on Wednesday, July 22nd. The company reported $3.61 EPS for the quarter, missing analysts' consensus estimates of $3.67 by ($0.06). Globe Life had a return on equity of 20.52% and a net margin of 19.58%.The firm had revenue of $1.60 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same period in the prior year, the business posted $3.05 EPS. The company's revenue for the quarter was up 8.0% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. As a group, equities research analysts anticipate that Globe Life Inc. will post 15.71 EPS for the current year.
Globe Life Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Monday, October 5th will be issued a $0.33 dividend. The ex-dividend date is Monday, October 5th. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.7%. Globe Life's dividend payout ratio is presently 8.76%.
Globe Life announced that its board has initiated a share repurchase program on Monday, August 10th that authorizes the company to repurchase $2.50 billion in shares. This repurchase authorization authorizes the company to repurchase up to 17.7% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company's board of directors believes its shares are undervalued.
Wall Street Analyst Weigh In
Several equities research analysts have commented on the stock. Truist Financial boosted their price target on shares of Globe Life from $180.00 to $185.00 and gave the stock a "buy" rating in a research report on Friday, April 24th. Morgan Stanley raised their price objective on shares of Globe Life from $181.00 to $208.00 and gave the company an "overweight" rating in a research report on Monday, July 6th. Weiss Ratings cut shares of Globe Life from a "buy (b)" rating to a "buy (b-)" rating in a research note on Monday, July 20th. JPMorgan Chase & Co. boosted their target price on shares of Globe Life from $181.00 to $201.00 and gave the stock an "overweight" rating in a report on Tuesday, July 21st. Finally, Jefferies Financial Group boosted their target price on shares of Globe Life from $147.00 to $166.00 and gave the stock a "hold" rating in a report on Friday, July 10th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have issued a Hold rating to the company's stock. According to MarketBeat, Globe Life currently has a consensus rating of "Moderate Buy" and a consensus price target of $191.67.
View Our Latest Analysis on GL
Insiders Place Their Bets
In other news, Director Cheryl Alston sold 8,258 shares of the firm's stock in a transaction on Thursday, June 25th. The stock was sold at an average price of $179.24, for a total value of $1,480,163.92. Following the completion of the sale, the director owned 16,621 shares of the company's stock, valued at $2,979,148.04. This trade represents a 33.19% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, EVP Michael Clay Majors sold 37,000 shares of Globe Life stock in a transaction on Wednesday, July 29th. The shares were sold at an average price of $178.64, for a total value of $6,609,680.00. Following the transaction, the executive vice president owned 53,518 shares in the company, valued at $9,560,455.52. This represents a 40.88% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 191,747 shares of company stock valued at $33,480,408 over the last quarter. 2.11% of the stock is owned by insiders.
Globe Life Profile
(
Free Report)
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company's product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Globe Life, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globe Life wasn't on the list.
While Globe Life currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report